» Articles » PMID: 33555506

Transglutaminase 2 Mediates Transcriptional Regulation Through BAF250a Polyamination

Overview
Journal Genes Genomics
Specialty Genetics
Date 2021 Feb 8
PMID 33555506
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Transglutaminase 2 (TG2) mediates protein modifications by crosslinking or by incorporating polyamine in response to oxidative or DNA-damaging stress, thereby regulating apoptosis, extracellular matrix formation, and inflammation. The regulation of transcriptional activity by TG2-mediated histone serotonylation or by Sp1 crosslinking may also contribute to cellular stress responses.

Objective: In this study, we attempted to identify TG2-interacting proteins to better understand the role of TG2 in transcriptional regulation.

Methods: Using a yeast two-hybrid assay to screen a HeLa cell cDNA library, we found that TG2 bound BAF250a, a core subunit of the cBAF chromatin remodeling complex, through an interaction between the TG2 barrel 1 and BAF250a C-terminal domains.

Results: TG2 was pulled down with a GST-BAF250a C-term fusion protein. Moreover, TG2 and BAF250a were co-fractionated using P11 chromatography, and co-immunoprecipitated. A transamidation reaction showed that TG2 mediated incorporation of polyamine into BAF250a. In glucocorticoid response-element reporter-expressing cells, TG2 overexpression increased the luciferase reporter activity in a transamidation-dependent manner. In addition, a comparison of genome-wide gene expression between wild-type and TG2-deficient primary hepatocytes in response to dexamethasone treatment showed that TG2 further enhanced or suppressed the expression of dexamethasone-regulated genes that were identified by a gene ontology enrichment analysis.

Conclusion: Thus, our results indicate that TG2 regulates transcriptional activity through BAF250a polyamination.

Citing Articles

Pharmacological Inhibition of Astrocytic Transglutaminase 2 Facilitates the Expression of a Neurosupportive Astrocyte Reactive Phenotype in Association with Increased Histone Acetylation.

Delgado T, Emerson J, Hong M, Keillor J, Johnson G Biomolecules. 2025; 14(12.

PMID: 39766301 PMC: 11673777. DOI: 10.3390/biom14121594.


Mass Spectrometry of Putrescine, Spermidine, and Spermine Covalently Attached to Universal Stress Protein and Bovine Albumin.

Schopfer L, Girardo B, Lockridge O, Larson M Biochem Res Int. 2024; 2024:7120208.

PMID: 38347948 PMC: 10861277. DOI: 10.1155/2024/7120208.


Identification and characterization of ARID1A-interacting proteins in renal tubular cells and their molecular regulation of angiogenesis.

Yoodee S, Peerapen P, Plumworasawat S, Malaitad T, Thongboonkerd V J Transl Med. 2023; 21(1):862.

PMID: 38017409 PMC: 10683333. DOI: 10.1186/s12967-023-04750-y.


Deletion of Transglutaminase 2 from Mouse Astrocytes Significantly Improves Their Ability to Promote Neurite Outgrowth on an Inhibitory Matrix.

Emerson J, Delgado T, Girardi P, Johnson G Int J Mol Sci. 2023; 24(7).

PMID: 37047031 PMC: 10094709. DOI: 10.3390/ijms24076058.


Pharmacological inhibition of astrocytic transglutaminase 2 facilitates the expression of a neurosupportive astrocyte reactive phenotype in association with increased histone acetylation.

Delgado T, Emerson J, Hong M, Keillor J, Johnson G bioRxiv. 2023; .

PMID: 36798305 PMC: 9934526. DOI: 10.1101/2023.02.06.527263.


References
1.
Aeschlimann D, Koeller M, Mosher D . Isolation of a cDNA encoding a novel member of the transglutaminase gene family from human keratinocytes. Detection and identification of transglutaminase gene products based on reverse transcription-polymerase chain reaction with degenerate primers. J Biol Chem. 1998; 273(6):3452-60. DOI: 10.1074/jbc.273.6.3452. View

2.
Ai L, Kim W, Demircan B, Dyer L, Bray K, Skehan R . The transglutaminase 2 gene (TGM2), a potential molecular marker for chemotherapeutic drug sensitivity, is epigenetically silenced in breast cancer. Carcinogenesis. 2008; 29(3):510-8. DOI: 10.1093/carcin/bgm280. View

3.
Abbasi N, Long T, Li Y, Yee B, Cho B, Hernandez J . DDX5 promotes oncogene C3 and FABP1 expressions and drives intestinal inflammation and tumorigenesis. Life Sci Alliance. 2020; 3(10). PMC: 7441524. DOI: 10.26508/lsa.202000772. View

4.
Choi K, Siegel M, Piper J, Yuan L, Cho E, Strnad P . Chemistry and biology of dihydroisoxazole derivatives: selective inhibitors of human transglutaminase 2. Chem Biol. 2005; 12(4):469-75. DOI: 10.1016/j.chembiol.2005.02.007. View

5.
De Laurenzi V, Melino G . Gene disruption of tissue transglutaminase. Mol Cell Biol. 2000; 21(1):148-55. PMC: 88788. DOI: 10.1128/MCB.21.1.148-155.2001. View